Pharma News
-
MHRA approves first oral advanced therapy for Crohn’s disease
The MHRA has approved the first marketing authorisation globally for the use of RINVOQ®▼ (upadacitinib) in Crohn’s disease. The Medicines…
Read More » -
MD Anderson partners with Federation Bio to develop microbiome
MD Anderson and Federation Bio will design and develop a synthetic microbial consortium to treat immunotherapy-resistant cancer patients. Credit: National…
Read More » -
Working in a Male-Dominated Field
It is no easy feat to break into a male-dominated field as a woman, no less the bio/pharmaceutical industry. Piper…
Read More » -
first biosimilar to HUMIRA available in US
AMJEVITA™, the first biosimilar to Humira® is now available in the US, based on four years of real-world experience in…
Read More » -
Antitrust watchdogs have pharma in their sights, and the landscape is getting thornier
Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. The Biden…
Read More » -
Pharmapack Europe Awards 2023 winners announced
Awards for innovative drug delivery solutions, reusable connected devices and recyclable packaging have been announced at Pharmapack Europe 2023. The…
Read More » -
Endevica Bio and Orbit Discovery unite to boost cachexia therapeutics
Orbit Discovery Limited – a company which focuses on peptide hits – has reached a research deal…
Read More » -
Cidara Therapeutics expands partnership with WuXi XDC
CD421 is Cidara’s lead oncology candidate. Credit: National Cancer Institute on Unsplash. Cidara Therapeutics has announced the expansion of its…
Read More » -
Bill & Melinda Gates Foundation funding for MIP Discovery
MIP Discovery – a company focused on detection reagents – has received a significant grant of funds…
Read More » -
US FDA approves GSK’s Jesduvroq to treat anaemia of CKD
GSK’s Jesduvroq is claimed to be the only HIF-PHI approved in the US. Credit: GSK plc. The US Food and…
Read More »